================================================================================

                                  EXHIBIT 31.1

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                        PURSUANT TO RULE 13a-14(a) OF THE
                   SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Raymond P.L. Cannefax, certify that:

1.     I have  reviewed  this annual  report on Form 10-KSB of Paradigm  Medical
       Industries, Inc.;

2.     Based on my  knowledge,  this  annual  report does not contain any untrue
       statement of a material fact or omit to state a material  fact  necessary
       to make the statements  made, in light of the  circumstances  under which
       such  statements  were made,  not  misleading  with respect to the period
       covered by this annual report;

3.     Based on my knowledge,  the  financial  statements,  and other  financial
       information  included  in  this  annual  report,  fairly  present  in all
       material respects the financial condition, results of operations and cash
       flows of the  registrant  as of, and for,  the periods  presented in this
       annual report;

4.     The  registrant's  other  certifying  officers and I are  responsible for
       establishing  and  maintaining  disclosure  controls and  procedures  (as
       defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
       and have:

              (a) Designed such disclosure  controls and  procedures,  or caused
              such  disclosure  controls and procedures to be designed under the
              Company's   supervision,   to  ensure  that  material  information
              relating   to   the   registrant,   including   its   consolidated
              subsidiaries, is made known to us by others within those entities,
              particularly  during  the period in which  this  annual  report is
              being prepared;

              (b) Evaluated the  effectiveness  of the  registrant's  disclosure
              controls and  procedures  and  presented in this annual report the
              Company's  conclusions  about the  effectiveness of the disclosure
              controls and  procedures,  as of the end of the period  covered by
              this annual report based on such evaluation; and

              (c) Disclosed in this annual report any change in the registrant's
              internal  control over financial  reporting  that occurred  during
              registrant's most recent fiscal quarter (the  registrant's  fourth
              fiscal  quarter  in  the  case  of  an  annual  report)  that  has
              materially affected, or is reasonably likely to materially affect,
              registration's internal control over financial reporting; and

5.     The registrant's other certifying officers and I have disclosed, based on
       the Company's most recent  evaluation of internal  control over financial
       reporting,  to the  registrant's  auditors  and the  audit  committee  of
       registrant's  board of directors (or persons  performing  the  equivalent
       functions):

              (a) All significant  deficiencies  and material  weaknesses in the
              design or operation of internal  control over financial  reporting
              which are reasonably  likely to adversely  affect the registrant's
              ability  to  record,  process,   summarize  and  report  financial
              information; and

              (b) Any fraud,  whether or not material,  that involves management
              or other employees who have a significant role in the registrant's
              internal control over financial reporting.


Date: March 31, 2007

                                           /s/ Raymond P.L. Cannefax
                                           -------------------------------------
                                           Raymond P.L. Cannefax
                                           President and Chief Executive Officer


--------------------------------------------------------------------------------